From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

UK Investor Show 2018 Video - John Dawson of Alliance Pharma

By Tom Winnifrith | Wednesday 9 May 2018


 


This is, of course, a big fave of Nigel Wray and he has done exceptionally well from Alliance Pharma (APH). It has also been a good share tip (twice) from myself and young Steve on the Nifty Fifty. The main man is John Dawson and he can explain the story going forward.

The 2019 UK Investor Show is on 30 March. Already more than one quarter of the 135 PLC stands are booked out while the big name speakers including Vin Murria, Nigel Wray, Mark Slater, Nick Leslau and myself and Malcolm Stacey are booked in to re-appear. Put the date in your diary and book your seats now HERE  - use the promotional code EARLYBIRD19 to get a 50% discount on both investor class and gold tickets - offer ends July 1.
 

The 2019 UK Investor Show is on 30 March. Already more than one quarter of the 135 PLC stands are booked out while the big name speakers including Vin Murria, Nigel Wray, Mark Slater, Nick Leslau and myself and Malcolm Stacey are booked in to re-appear. Put the date in your diary and book your seats now HERE  - use the promotional code EARLYBIRD19 to get a 50% discount on both investor class and gold tickets - offer ends July 1.


This story is available to all readers
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 08:27:05